Eric Burks, MD
Clinical Associate Professor
Boston University School of Medicine
Dept of Pathology

MD, University of New Mexico School of Medicine

Eric Burks, MD is a Clinical Associate Professor of Pathology at the Boston University School of Medicine. After graduating medical school, he had two fellowship: one in Surgical Pathology at Harvard Medical School and another in Hematopathology at Johns Hopkins Medical Institution. Only recently, as of April 2018, did he join Boston University. With him he brings extensive experience as a lecturer, mentor, and physician. His research is particularly notable given that he has received both the American Cancer Society Institutional Research Grant Medical Student Award and the American Society of Hematology Medical Student Award.
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kowalik CG, Palmer DA, Sullivan TB, Teebagy PA, Dugan JM, Libertino JA, Burks EJ, Canes D, Rieger-Christ KM. Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma. BJU Int. 2017 09; 120(3):428-440. PMID: 28432832; DOI: 10.1111/bju.13886;.
  2. Ricciardi R, Burks E, Schoetz DJ, Verma Y, Kershnar E, Kilpatrick MW, Tsipouras P, Walat RJ. Is there a gain in chromosome 3q in the pathway to anal cancer? Dis Colon Rectum. 2014 Oct; 57(10):1183-7. PMID: 25203374.
  3. Chen L, Kalady MF, Goldblum J, Seyidova-Khoshknabi D, Burks EJ, Roberts PL, Ricciardi R. Does reevaluation of colorectal cancers with inadequate nodal yield lead to stage migration or the identification of metastatic lymph nodes? Dis Colon Rectum. 2014 Apr; 57(4):432-7. PMID: 24608298.
  4. Burks EJ. Controlling the independent variables in the clinical study of prayer: the devil is in the details. Am Heart J. 2006 Oct; 152(4):e41-2. PMID: 16996819.
  5. Burks EJ, Loughran TP. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev. 2006 Sep; 20(5):245-66. PMID: 16530306; DOI: 10.1016/j.blre.2006.01.003;.
  6. Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC, Larson RS. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol. 2005 Oct; 29(10):1274-83. PMID: 16160468.
  7. Burks EJ, Loughran TP. Perspectives in the treatment of LGL leukemia. Leuk Res. 2005 Feb; 29(2):123-5. PMID: 15607357.
  8. Sillerud LO, Burks EJ, Brown WM, Brown DC, Larson RS. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution. J Pept Res. 2004 Oct; 64(4):127-40. PMID: 15357668; DOI: 10.1111/j.1399-3011.2004.00176.x;.
  9. Sillerud LO, Burks EJ, Wester MJ, Brown DC, Vijayan S, Larson RS. NMR-derived model of interconverting conformations of an ICAM-1 inhibitory cyclic nonapeptide. J Pept Res. 2003 Sep; 62(3):97-116. PMID: 12895272.
  10. Evans HL, Burks E, Viswanatha D, Larson RS. Utility of immunohistochemistry in bone marrow evaluation of T-lineage large granular lymphocyte leukemia. Hum Pathol. 2000 Oct; 31(10):1266-73. PMID: 11070120.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 7 distinct years, with a maximum of 2 publications in 2005 and 2006 and 2014

Contact for Mentoring:

670 Albany Street
Boston MA 02118
Google Map

Burks's Networks
Click the "See All" links for more information and interactive visualizations
Similar People